Baudax Bio, Inc. Made Big Gain
Thu, Mar 16, 2023 at 07:11 PM
Baudax Bio, Inc. (BXRX:NASDAQ) jumped higher at $1.92, a gain of 44.4%. On Thu, Mar 16, 2023, BXRX:NASDAQ hit a New 2-Week High of $1.92. The stock got featured on our News Catalysts scanner on Thu, Feb 23, 2023 at 09:47 AM in the 'INVESTOR UPDATE' category. From Thu, Mar 02, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Jan 24, 2023 at $6.89 with a volume of 47M+.
About Baudax Bio, Inc. (BXRX:NASDAQ)
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.
Top 10 Gainers:
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 97.59%
- OncoCyte Corporation (OCX:NASDAQ), 51.5%
- Baudax Bio, Inc. (BXRX:NASDAQ), 44.36%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 43.2%
- PureCycle Technologies Inc. (PCT:NASDAQ), 39.41%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 39.11%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 34.04%
- Peak Bio Inc Com (PKBO:NASDAQ), 31.56%
- Genelux Corporation (GNLX:NASDAQ), 27.78%
- Boqii Holding Limited American Depositary Shares representing Class A (BQ:NYSE), 25.81%